SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-011506
Filing Date
2023-04-13
Accepted
2023-04-13 16:10:23
Documents
10
Period of Report
2023-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A esperion-definitive2022pro.htm DEF 14A 863623
2 blookersigv2a.jpg GRAPHIC 5422
3 espe_rmxrgbxfcxpos002a.jpg GRAPHIC 44145
4 image1a.jpg GRAPHIC 15411
5 image2a.jpg GRAPHIC 74040
6 image3a.jpg GRAPHIC 60575
7 image4a.jpg GRAPHIC 112279
8 image5a.jpg GRAPHIC 102705
9 imagea.jpg GRAPHIC 14978
10 sheldonsignaturea.jpg GRAPHIC 20271
  Complete submission text file 0001628280-23-011506.txt   1483127
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35986 | Film No.: 23818473
SIC: 2834 Pharmaceutical Preparations